Jan 21, 2020
New Study Published on Nature Medicine Unveils the Power of AI in Predicting Osteoporotic Fractures
Oct 18, 2019
IOF: A Fracture Every 3 Seconds Worldwide - That's Osteoporosis
Oct 14, 2019
Global Fracture Fixation Devices Market 2019: Market is Expected to Increase at a CAGR of 5.9%, Reaching Nearly $11bn in 2023
Sep 26, 2019
Smith+Nephew introduces ground-breaking assurance program for TRIGEN(TM) INTERTAN(TM) Intertrochanteric Hip Fracture Nail
Sep 13, 2019
Largest Ever Hip Fracture Fixation Trial in Over 1,000 Patients Demonstrates Unprecedently Low Cut-Out Rates for X-BOLT® Device
Sep 11, 2019
New Report on Burden of Osteoporosis Highlights Huge and Growing Economic and Human Toll of the Disease
Jun 05, 2019
Smith & Nephew Launches the CONQUEST FN(TM) Femoral Neck Fracture System, a Fresh Approach to Hip Preservation Versus Current Treatment Options
Mar 12, 2019
Calcium and vitamin D supplementation are essential to help manage osteoporosis, especially following a hip fracture
Jan 23, 2019
Largest Ever Clinical Trial in Hip Fracture Fixation Completes One-Year Follow-Up in 1000th Patient
Oct 18, 2018
The Impact of Fragility Fractures due to Osteoporosis is Being Ignored
Jul 11, 2018
La Peer Health Systems Introduces a New Hip Surgery Program to Include an Advanced Hip Preservation Treatment Option
Mar 06, 2018
Study Validates Software Tool to Assess Mortality Risk in Older Patients with Orthopedic Fractures
Oct 20, 2017
The International Osteoporosis Foundation: Fractures Due to Osteoporosis Threaten Seniors' Independence
Oct 12, 2017
New System Designed to Enhance Implant Fixation for Hip Fracture Patients with Poor Bone Quality Launches in the U.S.
Oct 09, 2017
FDA Accepts Supplemental Biologics License Application For Prolia® (Denosumab) In Glucocorticoid-Induced Osteoporosis
Sep 25, 2017
Viking Therapeutics to Host Key Opinion Leader Event to Discuss Musculoskeletal Therapeutics in Hip Fracture and Other Settings
Sep 11, 2017
EVENITY(TM) (romosozumab) ARCH Study Results Published In The New England Journal Of Medicine
Sep 08, 2017
Amgen Highlights The Latest EVENITY(TM) (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting
Jul 31, 2017
Amgen Submits Supplemental Biologics License Application For Prolia® (denosumab) In Glucocorticoid-Induced Osteoporosis